A Study on Efficacy of Helical Tomotherapy Combined With Concurrent Chemotherapy ± EGFR Inhibitor After Induction Chemotherapy In Patients Affected By Locally Advanced Nasopharyngeal Carcinoma (LANC) With Carotid Artery Invasion And Risk Analysis of Massive Bleeding After Radiotherapy
KUN LIU,Jian Wei,qing sen Wang,Yang Wang,yan rong Luo,Lin Ma,shi ming Yang,xin xin Zhang
DOI: https://doi.org/10.21203/rs.3.rs-115813/v1
2020-12-01
Abstract:Abstract Purpose: Locally advanced nasopharyngeal carcinoma (LANC) often invades the parapharyngeal space and internal carotid artery. Patients with LANC and carotid artery invasion have a poor prognosis, which often result from massive neck hemorrhage after radiotherapy. We examined risk factors potentially influencing the therapeutic effects of radiotherapy in LANC patients with carotid artery invasion and the risk of massive neck hemorrhage. Methods: This retrospective study included 130 LANC patients with carotid artery invasion admitted to our hospital between January 2012 and September 2019. All patients were treated with induction chemotherapy followed by concurrent chemoradiotherapy ± epidermal growth factor receptor (EGFR) inhibitor. Effects of clinical factors and treatment regimens on prognosis were evaluated. Outcomes: The 5-year progression-free survival (PFS), distant metastasis-free survival (DMFS), local nodal recurrence-free survival (LNRFS), local recurrence-free survival (LRFS), nodal recurrence-free survival (NRFS) and overall survival (OS) of the 130 patients were 75.2%, 76.8%, 90.0%, 93.9%, 95.8%, 87.2%, respectively. The incidence of fatal bleeding after radiotherapy was 2.3% (3/130). For these 3 cases, the degree of carotid artery invasion was ≥270o, the primary site was the pharyngeal recess and the patients suffered nasopharyngeal necrosis after radiotherapy.Univariate analysis showed that clinical stage was negatively correlated with DMFS and PFS (P<0.05). The induction chemotherapy TP regimen, platinum-based concurrent chemotherapy and EGFR inhibitors (Nituzumab/Cetuximab) significantly improved PFS and DMFS (P 110 g/L had a higher PFS, DMFS and OS than patients with hemoglobin levels ≤110 g/L (P<0.05). Multivariate analysis showed that the EGFR inhibitor was an independent risk factor for PFS and DMFS, while the lowest hemoglobin level was an independent risk factor for OS. Conclusion: In LANC patients whose carotid artery invasion was <270o, helical tomotherapy combined with concurrent chemotherapy and EGFR inhibitor after induction chemotherapy had mild and tolerable side effects, better PFS and DMFS, and did not cause massive hemorrhage. In patients whose primary tumor was pharyngeal recess with carotid artery invasion ≥270o, diabetes or re-radiotherapy led to a higher risk of massive hemorrhage after radiotherapy.